Table 4.
Criteria for systemic involvement in AL amyloidosis with appropriate investigations
| System involved | Criteria Biopsy of affected or alternate site AND |
Tests required to demonstrate systemic involvement |
|---|---|---|
| Renal | Proteinuria of > 0.5 g/24 h (mainly albumin) | 24 h urine protein |
| Cardiac involvement | Lab or clinical evidence of involvement Echocardiography showing more than 12 mm wall thickness in absence of other causes |
Echo Troponin I N terminal pro brain natriuretic peptide ECG showing low voltage (< 5 mm) in all 12 leads |
| Liver |
Liver span > 15 cm in absence of heart failure Alkaline phosphatase > 1.5 times the normal range of lab |
CT scan or radionuclide imaging Alkaline phosphatase |
| Lung | Radiographic evidence of diffuse interstitial lung disease is taken as evidence of amyloidosis | CT scan/X ray |
| Gastro intestinal tract | Biopsy evidence with amyloid |